You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study

 

Online download statistics by month:

Online download statistics by month: January 2017 to March 2024

AbstractFullPdf
Jan 20172060
Feb 20173584
Mar 2017277108
Apr 2017013728
May 201709224
Jun 2017266613
Jul 2017717131
Aug 2017606016
Sep 2017515121
Oct 2017565517
Nov 2017454413
Dec 201725256
Jan 2018545417
Feb 2018565110
Mar 201875809
Apr 2018454613
May 2018626310
Jun 2018606211
Jul 201859597
Aug 2018454510
Sep 201826267
Oct 2018343413
Nov 201895958
Dec 201834347
Jan 20191081065
Feb 201927268
Mar 201937365
Apr 201921216
May 201925257
Jun 201927277
Jul 201921209
Aug 2019212117
Sep 201918177
Oct 2019272710
Nov 201922227
Dec 201917175
Jan 202010104
Feb 202018188
Mar 202022226
Apr 202010108
May 202017173
Jun 202010104
Jul 202016155
Aug 2020551
Sep 2020282810
Oct 202019177
Nov 202013138
Dec 2020222011
Jan 202111103
Feb 202113125
Mar 202115152
Apr 2021320
May 2021884
Jun 202117173
Jul 202111109
Aug 202110107
Sep 202110103
Oct 2021131319
Nov 202110919
Dec 202110102
Jan 2022999
Feb 2022672
Mar 202211115
Apr 202220187
May 2022222210
Jun 202227286
Jul 202220201
Aug 202230302
Sep 202224227
Oct 2022242312
Nov 2022212018
Dec 202211110
Jan 2023246914
Feb 202335354
Mar 202328289
Apr 2023161414
May 2023779
Jun 2023993
Jul 202312124
Aug 202312119
Sep 2023551
Oct 202319153
Nov 202313133
Dec 202318202
Jan 2024883
Feb 202411107
Mar 2024151444
Total21352499995